Skip to content

A Study Comparing Kantkari Ghrita and Vasa Avaleha for Treating Cough in Children

A comparitive clinical study to evaluate the efficacy of kantkari ghrita and vasavleha,in the management of kasa w.s.r cough in children due to varied etiology. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105622
Enrollment
50
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

None listed

Sponsors

Shri Dhanwantri Ayurvedic medical college Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with classical features of kasa roga 2. Patients having cough less than 1 month 3. The selection of the patients will be irrespective of sex , religion or socio economic status

Exclusion criteria

Exclusion criteria: 1. Patients presenting with symptoms of Tamak shwasa (Bronchial Asthma) , Kshayaja , and Kshataja Kasa 2. Serious Cardiovascular , Cerebrovascular , Renal and Liver diseases or severe illness 3. Any chronic illness diseases of Respiratory system example TB , Respiratory Distress syndrome , Chronic Lung disease , Bronchiectasis, Pleurisy etc. 4. Patients suffering from any systemic disorder and kasa as complication of any disease will be excluded from the study 5. Children with any congenital abnormality 6. History of food , Drug allergy of any kind 7. During course of treatment if the subject develops any acute illness requiring acute management , such patients will be excluded out of the study and continued with conventional treatment 8. Patient below age of 5 years and above 12 years

Design outcomes

Primary

MeasureTime frame
1. Improvement in subjective symptoms 2. Reduction in cough severity Timepoint: Follow up after 1 week

Secondary

MeasureTime frame
1. Improvement in associated symptoms 2. Quality of life 3. Safety and tolerabilityTimepoint: Follow up after 1 week

Countries

India

Contacts

Public ContactProf Dr Ritesh Murlidhar Kela

Shri Dhanwantri Ayurvedic medical college & Research Centre

drriteshkela@gmail.com9881259158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026